(Rac)-Tovinontrine
Product Specifications
UNSPSC Description
(Rac)-Tovinontrine ((Rac)-IMR-687) is a phosphodiesterase 9 (PDE9) inhibitor that increases cyclic guanosine monophosphate (cGMP) levels. (Rac)-Tovinontrine is promising for research of thalassemia[1].
Target Antigen
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/rac-tovinontrine.html
Smiles
O=C1NC(C2CN(CC2C)CC3=NC=CC=N3)=CN4C(C5CCOCC5)=NC=C14
Molecular Weight
394.47
References & Citations
[1]Aydinok Y. Highlights on the Luspatercept Treatment in Thalassemia[J]. Thalassemia Reports, 2023, 13(1): 77-84.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-114643/Rac-Tovinontrine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-114643/
Clinical Information
No Development Reported
CAS Number
1430840-90-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
